Volume 16 (2018): Issue 12 (Dec 2018)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xvi–xxiv
Oncology Research Program
Pages: xxviii–xxx
Reviewer Page
Pages: xxxi
An Oncologist's Letter to Santa: Bring Me Drugs!
By: Margaret Tempero
Pages: 1411
Letter to the Editor: Could Immunogenicity of Kaposi Sarcoma Be More Linked to Viral Antigens Than to the Tumor Mutational Burden?
By: Julie Delyon, Dimitri Arangalage, Barouyr Baroudjian, and Celeste Lebbe
Pages: 1418–1419
In Memoriam: Arti Hurria, MD
By: June M. McKoy
Pages: 1421–1422
Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib
By: Joshua B. Brown, Reetesh K. Pai, Melissa A. Burgess, Jennifer Chennat, and Amer H. Zureikat
Pages: 1424–1428
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
By: Robert I. Haddad, Christian Nasr, Lindsay Bischoff, Naifa Lamki Busaidy, David Byrd, Glenda Callender, Paxton Dickson, Quan-Yang Duh, Hormoz Ehya, Whitney Goldner, Megan Haymart, Carl Hoh, Jason P. Hunt, Andrei Iagaru, Fouad Kandeel, Peter Kopp, Dominick M. Lamonica, Bryan McIver, Christopher D. Raeburn, John A. Ridge, Matthew D. Ringel, Randall P. Scheri, Jatin P. Shah, Rebecca Sippel, Robert C. Smallridge, Cord Sturgeon, Thomas N. Wang, Lori J. Wirth, Richard J. Wong, Alyse Johnson-Chilla, Karin G. Hoffmann, and Lisa A. Gurski
Pages: 1429–1440
Metastatic Bulk Independently Predicts Outcomes for EGFR Precision Targeting in Colorectal Cancer
By: Jeremy D. Kratz, Nataliya V. Uboha, Sam J. Lubner, Daniel L. Mulkerin, Linda Clipson, Yanyao Yi, Menggang Yu, Kristina A. Matkowskyj, Noelle K. LoConte, and Dustin A. Deming
Pages: 1442–1450
Delays in Diagnosis and Treatment of Breast Cancer: A Safety-Net Population Profile
By: Kshama Jaiswal, Madelyne Hull, Anna L. Furniss, Reina Doyle, Natalia Gayou, and Elizabeth Bayliss
Pages: 1451–1457
New Cancer Drug Approvals From the Perspective of a Universal Healthcare System: Analyses of the Pan-Canadian Oncology Drug Review Recommendations
By: Saroj Niraula and Zoann Nugent
Pages: 1460–1466
Comparison of Overall Survival Between Preoperative Chemotherapy and Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma
By: Ali A. Mokdad, Rebecca M. Minter, Adam C. Yopp, Matthew R. Porembka, Sam C. Wang, Hong Zhu, Mathew M. Augustine, John C. Mansour, Michael A. Choti, and Patricio M. Polanco
Pages: 1468–1475
Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer
By: Claudia S.E.W. Schuurhuizen, Patricia Marino, Annemarie M.J. Braamse, Laurien M. Buffart, Florence Joly, Karim Fizazi, Muriel Habibian, Jean-Marie Boher, Michel Soulie, Stéphane Oudard, Inge R.H.M. Konings, Henk M.W. Verheul, Joost Dekker, and Gwenaelle Gravis
Pages: 1481–1488
Variation in Integrated Head and Neck Cancer Care: Impact of Patient and Hospital Characteristics
By: Lydia F.J. van Overveld, Robert P. Takes, Jozé C.C. Braspenning, Robert J. Baatenburg de Jong, Jan P. de Boer, John J.A. Brouns, Rolf J. Bun, Eric A. Dik, Boukje A.C. van Dijk, Robert J.J. van Es, Frank J.P. Hoebers, Barry Kolenaar, Arvid Kropveld, Ton P.M. Langeveld, Hendrik P. Verschuur, Jan G.A.M. de Visscher, Stijn van Weert, Max J.H. Witjes, Ludi E. Smeele, Matthias A.W. Merkx, and Rosella P.M.G. Hermens
Pages: 1491–1498
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
By: Jason Gotlib, Aaron T. Gerds, Prithviraj Bose, Mariana C. Castells, Michael W. Deininger, Ivana Gojo, Krishna Gundabolu, Gabriela Hobbs, Catriona Jamieson, Brandon McMahon, Sanjay R. Mohan, Vivian Oehler, Stephen Oh, Eric Padron, Philip Pancari, Nikolaos Papadantonakis, Animesh Pardanani, Nikolai Podoltsev, Raajit Rampal, Erik Ranheim, Lindsay Rein, David S. Snyder, Brady L. Stein, Moshe Talpaz, Swapna Thota, Martha Wadleigh, Katherine Walsh, Mary Anne Bergman, and Hema Sundar
Pages: 1500–1537
Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?
By: Kamya Sankar and Brady L. Stein
Pages: 1539–1545
Anti-EGFR Therapy in Right-Sided Metastatic Colorectal Cancer: Right or Wrong?
By: Benjamin A. Weinberg
Pages: 1547–1548
  • Collapse
  • Expand